NCT02660021

Brief Summary

Orthognathic surgery or corrective jaw surgery is indicated for conditions of the jaw and face that are related to structure or growth malfunctioning, orthodontic problems, or co-morbidities associated with skeletal disfigurement. Imaging is crucial in the assessment and treatment planning of orthognathic surgery patients. Until recently, two-dimensional (2D) imaging, through cephalometry, was standard practice. However, it showed several limitations. The introduction of the cone-beam computed tomography (CBCT) enabling three-dimensional (3D) imaging has caused a paradigm shift. Though widespread implementation in routine practice is not yet present. Our department is one of the pioneers in the world of 3D virtual treatment planning for orthognathic surgery. The "triple CBCT scan procedure" has been developed in-house and implemented already in 2009. The investigators aim to develop a prospective database registering 3D treatment planning data of all consecutive patients eligible for orthognathic surgery, performed by Prof. Swennen. Patient demographics, detailed virtual 3D treatment planning parameters and orthognathic surgery data are being collected during consecutive visits within the framework of routine practice. Development of a database registering 3D virtual treatment planning data of orthognathic surgery, will provide more information about potential patient, virtual planning and surgical factors influencing postoperative accuracy of jaw correction, long-term stability of the jawbone, long-term condylar resorption, or soft tissue response. In general, it could provide answers on research questions that have been examined in prior studies on 2D-imaging, but can now be re-examined in case of 3D-imaging. Moreover, registration of those results could function as a measurement of quality of care, or could be used for sample size calculation for future large multicenter prospective trials.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2010

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2010

Completed
5.5 years until next milestone

First Submitted

Initial submission to the registry

January 11, 2016

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 21, 2016

Completed
9.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

January 19, 2021

Status Verified

January 1, 2021

Enrollment Period

15.4 years

First QC Date

January 11, 2016

Last Update Submit

January 15, 2021

Conditions

Keywords

three-dimensional virtual treatment planningorthognathic surgery

Outcome Measures

Primary Outcomes (1)

  • Accuracy of hard tissue, soft tissue and teeth transfer after 3D planning, as measured with CBCT

    within 12 months postoperative

Secondary Outcomes (5)

  • Prevalence of patients with an indication for orthognathic surgery

    6 years

  • Accuracy of bone transfer, as measured through superimposition of 3D planning CBCT and postoperative CBCT

    4 weeks postoperative

  • Long-term stability, through clinical evaluation and superimposition of 3D planning CBCT and postoperative CBCT

    6 months postoperative

  • number of patients with condylar resorption

    until 12 months postoperative

  • number of patients with temporomandibular joint complications

    until 12 months postoperative

Other Outcomes (1)

  • sample size calculation for future large prospective trials, based on pilot data

    6 years

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All consenting patients, eligible for orthognathic surgery, performed at the General Hospital Saint-John Bruges, from July 1st 2010 onwards.

You may qualify if:

  • Patients of all ages
  • Both female and male patients
  • Patients should present themselves at the Department of Oral and Maxillofacial Surgery of the General Hospital Saint-John Bruges for orthognathic surgical treatment
  • Patients receive standardized cone-beam computed tomography (CBCT) image acquisition (i-CAT, Imaging sciences international, inc, Hatfield, USA) according to the "triple" CBCT scan protocol
  • Patients' orthognathic surgery should be prepared by a standardized setup of an augmented 3D virtual patient model in centric relation, with detailed occlusal and intercuspidation data using the "triple" voxel-based rigid registration protocol (Maxilim v2.2.2., Nobel Biocare c/o Medicim nv, Mechelen, Belgium)
  • Patients' surgery should be prepared preoperatively through 3D virtual planning steps performed with the same software, by the same surgeon (GS)
  • Patients should be operated by the same surgeon (GS)

You may not qualify if:

  • All patients that do not fit in the abovementioned description
  • Patients with posttraumatic deformity
  • Patients with congenital deformity
  • Patients with preprosthetic indication

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

General Hospital Saint-John Bruges

Bruges, Belgium

RECRUITING

MeSH Terms

Conditions

Jaw Abnormalities

Condition Hierarchy (Ancestors)

Jaw DiseasesMusculoskeletal DiseasesMaxillofacial AbnormalitiesCraniofacial AbnormalitiesMusculoskeletal AbnormalitiesStomatognathic DiseasesStomatognathic System AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Gwen Swennen, MD, LDS, DMD, PhD, FEBOMFS

    Maxillofacial Surgeon

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Araceli Diez-Fraile, VMD PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
maxillofacial surgeon, MD, LDS, DMD, PhD, FEBOMFS

Study Record Dates

First Submitted

January 11, 2016

First Posted

January 21, 2016

Study Start

July 1, 2010

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

January 19, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

Locations